Percyquinnin, a process for its production and its use as a pharmaceutical

US6596518B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Cordula Hopmann · Berlin, DE
• Michael Kurz · Neustadt, DE
• Guenter Mueller · Pocking, DE
• Luigi Toti · Hochheim, DE

Key dates

• Filing date: Apr 6, 2001
• Grant date: Jul 22, 2003
• Expiry date: Apr 6, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12R2001/645
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to a compound named Percyquinnin that is obtainable by cultivating a basidiomycetes Stereum complicatum (DSM 13303), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Percyquinnin and to the use of Percyquinnin and its pharmaceutically acceptable salts as pharmaceuticals, in particular to their use as inhibitors of lipase.